Clinical trial
Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis
NCT00390975 · Novartis, Industry · Terminated
Key facts
| NCT number | NCT00390975 |
|---|---|
| Title | Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis |
| Official title | An Open-label Pilot Trial to Assess the Effect of Tegaserod on Improvement of Gastric Emptying in Patients With Diabetic Gastroparesis and Upper Gastrointestinal Symptoms |
| Lead sponsor | Novartis, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Gastroparesis, Diabetes |
| Intervention type | Drug |
| Interventions | Tegaserod |
| Enrollment | 40 |
| Start date | Jan 1, 2007 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Oct 23, 2006 |
| Last update posted | May 4, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: